Contact

Our portfolio

ForceSense

ForceSense develops and sells the Lapron boxtrainer, a portable device for laparoscopic surgery training. Their integrated sensor system tracks performance and benchmarks it against a database. ForceSense’s technology allows for unsupervised, at-home surgical practice. The company is committed to enhancing surgical training through innovative simulation tools.

  • Institute: Amsterdam UMC
Industry: Simulation, Surgery
  • Founding year: 2010
Visit website

Want to get in contact about ForceSense?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
SigmaScreening
Developing a painless and more accurate mammography technology for breast cancer detection.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
SigmaScreening
Developing a painless and more accurate mammography technology for breast cancer detection.
Explore full AAV portfolio
Contact